Inicio › Enlaces principales continuación... › Todo lo publicado en la página › Prevalence, Awareness, Treatment, and Control Rate of ... › Prevalence, Awareness, Treatment, and Control Rate of Hypertension in HIV-Infected Patients: The HIV-HY Study

Prevalence, Awareness, Treatment, and Control Rate of Hypertension in HIV-Infected Patients: The HIV-HY Study

La reanudación del Diplomado  Atención al Paciente Hipertenso se efectuará  el día viernes 4 de Septiembre, a las 9 am.  y que se efectuará, como está programado,  en el Anfiteatro del Hospital Calixto García. La coordinadora de este módulo de " HTA y cerebro" es la Profesora Dra.  Yamilé Valdés   con la que  puden comunicarse  por: 

Teléfono  7838 2205    o  por Email:  yamile.valdes@infomed.sld.cu

Prevalence, Awareness, Treatment, and Control Rate of Hypertension in HIV-Infected Patients: The HIV-HY Study

Riesgo-cardiovascularPor: Giuseppe Vittorio De Socio, Elena Ricci, Paolo Maggi, Giustino Parruti, Giacomo Pucci, Antonio Di Biagio, Leonardo Calza, Giancarlo Orofino, Laura Carenzi, Enisia Cecchini, Giordano Madeddu, Tiziana Quirino, Giuseppe Schillaci  for the CISAI study group.  American Journal of Hypertension, Volume 27 Issue 2, Pp. 222-228, February 2014.

We aimed to assess the prevalence of hypertension in an unselected human immunodeficiency virus (HIV)–infected population and to identify factors associated with hypertension prevalence, treatment, and control. Atherosclerotic cardiovascular disease (CVD), a leading cause of morbidity and mortality in the general population, is an increasing concern for human immunodeficiency virus (HIV)–infected patients. HIV-infected individuals are exposed to accelerated vascular aging,1 and this issue has become even more relevant since antiretroviral therapy has impressively extended the life span of HIV-infected individuals.